Industrial Pharmacy
pH Sensitivity in Liquid Oral Dosage Forms
When developing liquid oral dosage forms, one critical consideration is pH sensitivity—the impact of pH on the stability, solubility, and bioavailability of active pharmaceutical ingredients (APIs). This factor can make or break the formulation process and ultimately determine the drug’s efficacy and safety for patients. During preformulation, it’s essential to: ... Read More
Temperature Sensitivity in Liquid Dosage Form Development
In the development of liquid oral dosage forms, temperature sensitivity is a critical factor that impacts solubility, stability, and overall performance. Preformulation studies help us understand how temperature fluctuations can affect the formulation, ensuring that the drug maintains efficacy and safety under various conditions. Key considerations include:Solubility & Dissolution: Temperature ... Read More
Excipient Compatibility in Liquid Oral Dosage Form
In the development of liquid oral dosage forms, “excipient compatibility” is essential to ensure the stability, efficacy, and safety of the final product. The choice of excipients plays a pivotal role in determining how well the active pharmaceutical ingredient (API) performs, and how it interacts with other components within the ... Read More
Exploring Preformulation Studies in Liquid Oral Dosage Forms
When developing liquid oral dosage forms, preformulation studies are key to ensuring the product’s stability, efficacy, and patient compliance. These studies help identify the ideal formulation parameters, including: Solubility & Stability: Assessing the drug’s solubility in different solvents and conditions to predict shelf-life and storage needs. pH Sensitivity: Understanding the ... Read More
Invisible Discriminatory Parameter in Dissolution
It’s not rpm, it’s your dissolution specs – Q value + time point. Sceptical? Well here’s a case study that makes this obvious. In this study, dissolution was run on Progesterone 100 mg Soft gelatin capsules. Dissolution profiles of two Test batches with different API particle sizes – Test 1 ... Read More
Safe Impurity Limit for Pharmaceuticals
The fastest way to sabotage your own submission? Set impurity limits to “look safe” Both sides think they’re protecting the product. Sometimes both are wrong! Here’s what actually happens: Set the limit too tight – based on early data: What started as a ‘conservative’ decision now stretches your development timeline. ... Read More
Dissolution Method Validation Across Multiple Strengths
Last week I came across a LinkedIn post claiming you can validate one ‘pseudo/ worst-case strength’ because same API = same method performance. While it’s true that ‘representative’ strengths ARE used in method validation. But for dissolution, this assumption is an oversimplification to the point where it’s not correct. Why? ... Read More
Stabilizing a Pharmaceutical Formulation through Packaging
In pharmaceutical development, formulation stability is often discussed only in terms of excipient selection and process optimization. However, in real-world product development, stability is achieved through an integrated approach involving formulation, process, and packaging together. Packaging is not merely a container. It is a functional component of the drug product ... Read More
End-to-End DoE Implementation Framework
1. Define the ObjectiveEvery DoE must start with a clearly defined objective. This answers the fundamental question: Why are we doing this experiment?Typical objectives include identifying critical factors, optimizing a formulation or process, or resolving a specific quality or performance issue. A weak objective leads to weak learning. 2. Identify ... Read More
Developing an Effective Control Strategy within a QbD Framework
Quality by Design is not about documentation. It is about understanding how materials and processes influence product quality and patient safety. The pharmaceutical control strategy develops step by step, as outlined below: I. Identification of Critical Material Attributes (CMAs) CMAs are physical or functional properties of raw materials that can ... Read More
Types of Variation Filings in UK and Europe
In pharmaceutical regulatory affairs, product life does not end with approval. Every post-approval change must be scientifically justified and filed through a defined regulatory pathway. These post-approval submissions are known as Variation Filings, and both the European Union and the United Kingdom follow structured classification systems to manage them. In ... Read More